AbCellera Biologics Inc (ABCL) stock saw a decline, ending the day at $2.92 which represents a decrease of $-0.11 or -3.63% from the prior close of $3.03. The stock opened at $2.98 and touched a low ...

KeyBanc lowered the firm’s price target on AbCellera (ABCL) to $4 from $5 and keeps an Overweight rating on the shares. The firm believes there ...

AbCellera Biologics Inc (ABCL) stock saw a decline, ending the day at $3.03 which represents a decrease of $-0.25 or -7.62% from the prior close of $3.28. The stock opened at $3.26 and touched a low ...

We recently published a list of the 12 Best Canadian Penny Stocks to Buy According to Analysts. In this article, we are going ...

Today, we put AbCellera Biologics Inc. (NASDAQ:ABCL) in the spotlight. It is our first look at this somewhat unique developmental concern since our last article on this name in mid-February of ...

So, the natural question for AbCellera Biologics (NASDAQ:ABCL) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual ...

AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) shares rose 3.3% on Friday .The company traded as high as $2.80 and last traded at $2.80. Approximately 151,683 shares were traded during ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies ...